SGMO·800677106·US·equity·Healthcare - Biotechnology-13D/G
SGMO (SANGAMO THERAPEUTICS INC) is held by 52 institutional investors as of Q1 2026. Largest holders: TWO SIGMA INVESTMENTS, LP ($1.5M), BALYASNY ASSET MANAGEMENT L.P. ($1.3M), GEODE CAPITAL MANAGEMENT, LLC ($1.1M). Net institutional sentiment: Mixed.
See how SGMO's score breaks down across 4 SEC sources
Showing 1-20 of 61
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer